{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T11:38:46Z","timestamp":1700653126236},"reference-count":17,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T00:00:00Z","timestamp":1124409600000},"content-version":"vor","delay-in-days":3121,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[1997,2]]},"abstract":"<jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> To investigate the relation between increased fetal nuchal translucency thickness at 10\u201314 weeks of gestation and maternal\u2013fetal infection.<\/jats:p><jats:p><jats:bold>Design\n\t\t\t\t\t<\/jats:bold> Prospective study.<\/jats:p><jats:p><jats:bold>Setting\n\t\t\t\t\t<\/jats:bold> Harris Birthright Research Centre for Fetal Medicine.<\/jats:p><jats:p><jats:bold>Population\n\t\t\t\t\t<\/jats:bold> Four hundred and twenty\u2010six chromosomally normal pregnancies with increased fetal nuchal translucency thickness at 10\u201314 weeks of gestation and 63 with \u2018unexplained\u2019 second or third trimester fetal nuchal oedema or hydrops.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> Maternal serum infection screening and investigations for fetal infection in those with evidence of recent maternal infection.<\/jats:p><jats:p><jats:bold>Main outcome measures\n\t\t\t\t\t<\/jats:bold> Maternal and fetal infection.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> Evidence of recent maternal infection was present in six of the 426 pregnancies (1.4%) with increased fetal nuchal translucency thickness at 10\u201314 weeks, but in all cases a healthy infant was born with no evidence of infection. In contrast,\u2018unexplained\u2019 second or third\u2010trimester fetal hydrops was associated with maternal infection in six of the pregnancies (9.5%) and in all cases there was evidence of fetal infection.<\/jats:p><jats:p><jats:bold>Conclusions\n\t\t\t\t\t<\/jats:bold> Maternal\u2013fetal infection is one of the causes of second or third trimester nuchal oedema or fetal hydrops. In contrast, the presence of increased nuchal translucency in the first trimester is not a marker of either maternal or fetal infection.<\/jats:p>","DOI":"10.1111\/j.1471-0528.1997.tb11047.x","type":"journal-article","created":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T11:06:02Z","timestamp":1124449562000},"page":"212-215","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Increased fetal nuchal translucency thickness at 10\u201314 weeks: is screening for maternal\u2013fetal infection necessary?"],"prefix":"10.1111","volume":"104","author":[{"given":"N. J.","family":"Sebire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. J. M.","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zuckerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. H.","family":"Nicolaides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,19]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1994.tb11946.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1995.tb10902.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0705.1996.07040245.x"},{"key":"e_1_2_5_5_2","first-page":"52","article-title":"Non\u2010immune hydrops fetalis: diagnosis and management","volume":"9","author":"Holzgreve W","year":"1985","journal-title":"Semin Perinatol"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1985.tb01446.x"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320340313"},{"key":"e_1_2_5_8_2","first-page":"1003","article-title":"Intrauterine resolution of non\u2010immune hydrops associated with cytomegalovirus infection","volume":"71","author":"Fadel HE","year":"1988","journal-title":"Obstet Gynecol"},{"key":"e_1_2_5_9_2","first-page":"501","article-title":"Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection","volume":"75","author":"Peters MT","year":"1990","journal-title":"Obstet Gynecol"},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/jama.1986.03380140074025","article-title":"Primary cytomegalovirus infection in pregnancy. Incidence, transmission to the fetus and clinical outcome","volume":"256","author":"Stagno S","year":"1986","journal-title":"JAMA"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198511143132006"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549309008574"},{"key":"e_1_2_5_13_2","first-page":"285","article-title":"The prevalence and incidence of toxoplasma antibodies in pregnant women","volume":"29","author":"Franklin DM","year":"1993","journal-title":"Israel J Med Sci"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/pd.1970140309"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0705.1991.01040241.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.5.1360"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.300.6733.1166"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.42.12.1281"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.1997.tb11047.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.1997.tb11047.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:39:07Z","timestamp":1697416747000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.1997.tb11047.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,2]]}},"alternative-id":["10.1111\/j.1471-0528.1997.tb11047.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.1997.tb11047.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,2]]},"assertion":[{"value":"2005-08-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}